Learning Materials

Videos and slides for Module 3 are available to view below.

Lecture

1

Case study of in-process curing of EURADRAGIT NM30D (Thomas Dassinger, Evonik Industries, AG)

Lecture

2

Introduction to Inhalation Products (Andy Rignall, AstraZeneca)

Lecture

3

QbD for Inhalation Products I: Container/Closure & Supply Chain Considerations(Andy Rignall, AstraZeneca)

Lecture

4

QbD for Inhalation Products II: Biopharmaceutics & Product Characterisation Considerations (Andy Rignall, AstraZeneca)

Lecture

5

QbD for Inhalation Products III: Case Study (Andy Rignall, AstraZeneca)

Lecture

6

Practical application of QbD to freeze drying process development – Part 1 (Paul Matejtschuck, MHRA)

Lecture

7

Practical application of QbD to freeze drying process development – Part 2 (Paul Matejtschuck, MHRA)

Lecture

8

Applications of QbD in Lyophilisation (Matthew Brown, Lyosolutions)

Lecture

9

Analytical methods and QbD I: a synopsis of the traditional approach and its weaknesses (Pauline McGregor, PMcG Consulting)

Lecture

10

Analytical methods and QbD II: relating QbD to analytical methods (Pauline McGregor, PMcG Consulting)

Lecture

11

Analytical Methods and QbD III: applying QbD to analytical methods – Stage 1 – part 1 (Pauline McGregor, PMcG Consulting)

Lecture

12

Analytical Methods and QbD IV: applying QbD to analytical methods – Stage 1 – part 2 (Pauline McGregor, PMcG Consulting)

Lecture

13

Analytical Methods and QbD V: applying QbD to analytical methods – Stage 2 and 3 (Pauline McGregor, PMcG Consulting)

Lecture

14

QbD for Sterile Products (Tim Lukas, Pfizer)

Lecture

15

Risk Assessment & Defining Commercial Manufacturing Process (Rachel Brody, Pfizer)

Leave a Reply